Home / Business and Economy / Dexcom Beats Estimates, Raises Full-Year Outlook
Dexcom Beats Estimates, Raises Full-Year Outlook
31 Jul
Summary
- Dexcom's revenue forecast was raised for the full year.
- Continuous glucose monitors show sustained demand.
- Company shares rose over 4% after the announcement.
Medical device manufacturer Dexcom announced a raised full-year revenue forecast, exceeding quarterly expectations. The company attributes its strong performance to ongoing high demand for its continuous glucose monitors.
These devices are crucial for tracking blood sugar levels, indicating a robust market for diabetes management technology. The positive financial news led to a surge in Dexcom's stock, which climbed more than 4% in after-hours trading on Thursday.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
